Showing results (81-90 of 407) with videos related to
Sort By:
Pageof 41
Infectious Disease Clinics of North America|November 14, 2009
Pathogens resistant to antibacterial agentsLuke F Chen, Teena Chopra, Keith S KayeThe Medical Clinics of North America|June 18, 2011
Pathogens resistant to antibacterial agentsLuke F Chen, Teena Chopra, Keith S KayeAntimicrobial Agents and Chemotherapy|May 2, 2012
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coliTeena Chopra, Dror Marchaim, Jennifer Veltman, et al.Journal of Clinical Microbiology|February 23, 2007
Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumanniiDror Marchaim, Shiri Navon-Venezia, David Schwartz, et al.Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 28, 2024
The epidemiology of Stenotrophomonas maltophilia and Achromobacter xylosoxidans infectionsShani Zilberman-Itskovich, Edward Cohen, Leonid-Arie Ploshansky, et al.Infectious Disease Clinics of North America|February 27, 2026
Blueprint for a Successful Infection Prevention ProgramSorabh Dhar, Amanda Valyko, Keith S Kaye, et al.Antimicrobial Agents and Chemotherapy|December 24, 2008
Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infectionsRonald P Olson, Lizzie J Harrell, Keith S KayeInternational Journal of Antimicrobial Agents|February 4, 2019
Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experienceChristopher J Destache, David J Guervil, Keith S KayeVirulence|July 8, 2016
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant EnterobacteriaceaeJoshua T Thaden, Jason M Pogue, Keith S KayeInternational Journal of Antimicrobial Agents|November 24, 2016
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?Jason M Pogue, Jessica K Ortwine, Keith S KayePageof 41